143 related articles for article (PubMed ID: 17415713)
1. Expression of oncofetal RNA-binding protein CRD-BP/IMP1 predicts clinical outcome in colon cancer.
Dimitriadis E; Trangas T; Milatos S; Foukas PG; Gioulbasanis I; Courtis N; Nielsen FC; Pandis N; Dafni U; Bardi G; Ioannidis P
Int J Cancer; 2007 Aug; 121(3):486-94. PubMed ID: 17415713
[TBL] [Abstract][Full Text] [Related]
2. CRD-BP/IMP1 expression characterizes cord blood CD34+ stem cells and affects c-myc and IGF-II expression in MCF-7 cancer cells.
Ioannidis P; Mahaira LG; Perez SA; Gritzapis AD; Sotiropoulou PA; Kavalakis GJ; Antsaklis AI; Baxevanis CN; Papamichail M
J Biol Chem; 2005 May; 280(20):20086-93. PubMed ID: 15769738
[TBL] [Abstract][Full Text] [Related]
3. Two Isoforms of the RNA Binding Protein, Coding Region Determinant-binding Protein (CRD-BP/IGF2BP1), Are Expressed in Breast Epithelium and Support Clonogenic Growth of Breast Tumor Cells.
Fakhraldeen SA; Clark RJ; Roopra A; Chin EN; Huang W; Castorino J; Wisinski KB; Kim T; Spiegelman VS; Alexander CM
J Biol Chem; 2015 May; 290(21):13386-400. PubMed ID: 25861986
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of an mRNA-binding protein in human colorectal cancer.
Ross J; Lemm I; Berberet B
Oncogene; 2001 Oct; 20(45):6544-50. PubMed ID: 11641779
[TBL] [Abstract][Full Text] [Related]
5. IMP1 promotes tumor growth, dissemination and a tumor-initiating cell phenotype in colorectal cancer cell xenografts.
Hamilton KE; Noubissi FK; Katti PS; Hahn CM; Davey SR; Lundsmith ET; Klein-Szanto AJ; Rhim AD; Spiegelman VS; Rustgi AK
Carcinogenesis; 2013 Nov; 34(11):2647-54. PubMed ID: 23764754
[TBL] [Abstract][Full Text] [Related]
6. 8q24 Copy number gains and expression of the c-myc mRNA stabilizing protein CRD-BP in primary breast carcinomas.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Int J Cancer; 2003 Mar; 104(1):54-9. PubMed ID: 12532419
[TBL] [Abstract][Full Text] [Related]
7. CRD-BP mediates stabilization of betaTrCP1 and c-myc mRNA in response to beta-catenin signalling.
Noubissi FK; Elcheva I; Bhatia N; Shakoori A; Ougolkov A; Liu J; Minamoto T; Ross J; Fuchs SY; Spiegelman VS
Nature; 2006 Jun; 441(7095):898-901. PubMed ID: 16778892
[TBL] [Abstract][Full Text] [Related]
8. Posttranscriptional regulation of colonic epithelial repair by RNA binding protein IMP1/IGF2BP1.
Chatterji P; Williams PA; Whelan KA; Samper FC; Andres SF; Simon LA; Parham LR; Mizuno R; Lundsmith ET; Lee DS; Liang S; Wijeratne HS; Marti S; Chau L; Giroux V; Wilkins BJ; Wu GD; Shah P; Tartaglia GG; Hamilton KE
EMBO Rep; 2019 Jun; 20(6):. PubMed ID: 31061170
[TBL] [Abstract][Full Text] [Related]
9. Targeted knockdown of the RNA-binding protein CRD-BP promotes cell proliferation via an insulin-like growth factor II-dependent pathway in human K562 leukemia cells.
Liao B; Patel M; Hu Y; Charles S; Herrick DJ; Brewer G
J Biol Chem; 2004 Nov; 279(47):48716-24. PubMed ID: 15355996
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of GLI1 Expression by Targeting the CRD-BP-GLI1 mRNA Interaction Using a Specific Oligonucleotide.
Mehmood K; Akhtar D; Mackedenski S; Wang C; Lee CH
Mol Pharmacol; 2016 Jun; 89(6):606-17. PubMed ID: 27036131
[TBL] [Abstract][Full Text] [Related]
11. CRD-BP: a c-Myc mRNA stabilizing protein with an oncofetal pattern of expression.
Ioannidis P; Mahaira L; Papadopoulou A; Teixeira MR; Heim S; Andersen JA; Evangelou E; Dafni U; Pandis N; Trangas T
Anticancer Res; 2003; 23(3A):2179-83. PubMed ID: 12894594
[TBL] [Abstract][Full Text] [Related]
12. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
[TBL] [Abstract][Full Text] [Related]
13. Expression of the RNA-binding protein CRD-BP in brain and non-small cell lung tumors.
Ioannidis P; Kottaridi C; Dimitriadis E; Courtis N; Mahaira L; Talieri M; Giannopoulos A; Iliadis K; Papaioannou D; Nasioulas G; Trangas T
Cancer Lett; 2004 Jun; 209(2):245-50. PubMed ID: 15159028
[TBL] [Abstract][Full Text] [Related]
14. IMP1 promotes choriocarcinoma cell migration and invasion through the novel effectors RSK2 and PPME1.
Hsieh YT; Chou MM; Chen HC; Tseng JJ
Gynecol Oncol; 2013 Oct; 131(1):182-90. PubMed ID: 23911878
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of IQGAP1 in advanced colorectal cancer correlates with poor prognosis-critical role in tumor invasion.
Hayashi H; Nabeshima K; Aoki M; Hamasaki M; Enatsu S; Yamauchi Y; Yamashita Y; Iwasaki H
Int J Cancer; 2010 Jun; 126(11):2563-74. PubMed ID: 19856315
[TBL] [Abstract][Full Text] [Related]
16. Expression of the RNA-binding protein IMP1 correlates with poor prognosis in ovarian carcinoma.
Köbel M; Weidensdorfer D; Reinke C; Lederer M; Schmitt WD; Zeng K; Thomssen C; Hauptmann S; Hüttelmaier S
Oncogene; 2007 Nov; 26(54):7584-9. PubMed ID: 17546046
[TBL] [Abstract][Full Text] [Related]
17. Mammary tumor induction in transgenic mice expressing an RNA-binding protein.
Tessier CR; Doyle GA; Clark BA; Pitot HC; Ross J
Cancer Res; 2004 Jan; 64(1):209-14. PubMed ID: 14729626
[TBL] [Abstract][Full Text] [Related]
18. IGF2BP1/IMP1 Deletion Enhances a Facultative Stem Cell State via Regulation of MAP1LC3B.
Parham LR; Williams PA; Katada K; Nettleford SK; Chatterji P; Acheampong KK; Danan CH; Ma X; Simon LA; Naughton KE; Mizuno R; Karakasheva T; McMillan EA; Whelan KA; Brady DC; Shaffer SM; Hamilton KE
Cell Mol Gastroenterol Hepatol; 2024; 17(3):439-451. PubMed ID: 38081361
[TBL] [Abstract][Full Text] [Related]
19. Grifolin, neogrifolin and confluentin from the terricolous polypore Albatrellus flettii suppress KRAS expression in human colon cancer cells.
Yaqoob A; Li WM; Liu V; Wang C; Mackedenski S; Tackaberry LE; Massicotte HB; Egger KN; Reimer K; Lee CH
PLoS One; 2020; 15(5):e0231948. PubMed ID: 32369483
[TBL] [Abstract][Full Text] [Related]
20. Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice.
Hansen TV; Hammer NA; Nielsen J; Madsen M; Dalbaeck C; Wewer UM; Christiansen J; Nielsen FC
Mol Cell Biol; 2004 May; 24(10):4448-64. PubMed ID: 15121863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
